8225 — China Health Share Price
0.000.00%
Last trade - 00:00- HK$147.31m
- HK$129.72m
- CNY26.45m
- 40
- 19
- 60
- 32
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.97 | ||
| Price to Tang. Book | 1.97 | ||
| Price to Free Cashflow | 16.24 | ||
| Price to Sales | 5.23 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -20.76% | ||
| Return on Equity | -18.71% | ||
| Operating Margin | -54.71% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 83.06 | 83.6 | 13.09 | 21.43 | 26.45 | n/a | n/a | -15.99% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +69.49 | -17.73 | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
China Health Group Inc. is a Hong Kong-based investment holding company principally engaged in the provision of terminal medical services. The Company provides hospital clinical research and product promotion services, hospital management services, mobile telemedicine services, special expertise therapy services and rehabilitation and medical tours services. Its clinical research services include Phase I clinical and bioequivalence studies, Phase IV post-marketing clinical study, data management and medical statistics and medical administration-related services, among others. Its hospital management services include Internet healthcare services and drug delivery services, such as Chinese best doctor and My doctor 999, among others.
Directors
- Xia Guo CHM
- Liang Li FID
- Tuo Jin CTO
- Xue Mei Song CCO
- Tarun Gupta OTH
- Albert Qin OTH
- Yuen Ling Lam SEC (54)
- Yan Xing SEC
- Michael Su NED (44)
- Zhen Ling NID (52)
- Bin Hui Ni NID
- Rui Qiu NID (42)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- May 21st, 2002
- Public Since
- July 10th, 2003
- No. of Employees
- 42
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 995,351,660
- Address
- Block 17, BEIJING, 100089
- Web
- http://www.chgi.net
- Phone
- Auditors
- KTC Partners CPA Limited
Upcoming Events for 8225
Similar to 8225
Abbisko Cayman
Stock Exchange of Hong Kong Limited
Akeso
Stock Exchange of Hong Kong Limited
Alphamab Oncology
Stock Exchange of Hong Kong Limited
Antengene
Stock Exchange of Hong Kong Limited
Ascentage Pharma International
Stock Exchange of Hong Kong Limited
FAQ
What is the China Health share price?
As of Today at 19:52 UTC, shares in China Health are trading at HK$0.15. This share price information is delayed by 15 minutes.
How has the China Health share price performed this year?
Shares in China Health last closed at HK$0.15 and the price had moved by +23.33% over the past 365 days. In terms of relative price strength the China Health share price has outperformed the FTSE Developed Asia Pacific Index by +24.74% over the past year.
What are the analyst and broker recommendations for China Health?
There is no consensus recommendation for this security.
Find out moreWhat is the China Health dividend yield?
China Health does not currently pay a dividend.
Does China Health pay a dividend?
China Health does not currently pay a dividend.
When does China Health next pay dividends?
China Health does not currently pay a dividend.
How do I buy China Health shares?
To buy shares in China Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of China Health?
As of the previous close price of HK$0.15, shares in China Health had a market capitalisation of HK$147.31m.
Where are China Health shares listed?
Here are the trading details for China Health:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 8225
What kind of share is China Health?
Based on an overall assessment of its quality, value and momentum China Health is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a China Health share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the China Health share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like China Health. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +0.53%.
As of the last closing price of HK$0.15, shares in China Health were trading -1.69% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the China Health PE Ratio?
The China Health PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$0.15.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of China Health?
China Health's management team is headed by:
- Xia Guo - CHM
- Liang Li - FID
- Tuo Jin - CTO
- Xue Mei Song - CCO
- Tarun Gupta - OTH
- Albert Qin - OTH
- Yuen Ling Lam - SEC
- Yan Xing - SEC
- Michael Su - NED
- Zhen Ling - NID
- Bin Hui Ni - NID
- Rui Qiu - NID